Takeda Pharmaceutical Company Limited Key Management Personnel Compensation Shortterm Employee Benefits
Takeda Pharmaceutical Company Limited (TKPHF) reported Key Management Personnel Compensation Shortterm Employee Benefits of JPY 1.88 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits · last filed 2025-06-25
| Period end | Key Management Personnel Compensation Shortterm Employee Benefits 12 month |
|---|---|
| 2025-03-31 | 1.88B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 1.84B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 1.64B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 1.61B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 1.66B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 2.44B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 2.23B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 1.33B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 1.48B JPY 20-F · filed 2019-06-27 |